These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

987 related items for PubMed ID: 30555042

  • 1. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B, Cao Y, Meng G, Qian L, Xu T, Yan C, Luo O, Wang S, Wei J, Ding Y, Yu D.
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [Abstract] [Full Text] [Related]

  • 2. COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling.
    Cai MN, Chen DM, Chen XR, Gu YR, Liao CH, Xiao LX, Wang JL, Lin BL, Huang YH, Lian YF.
    Cell Oncol (Dordr); 2024 Oct; 47(5):1897-1910. PubMed ID: 39080215
    [Abstract] [Full Text] [Related]

  • 3. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, Zhou Y, Liu Z, Liu Y, Hu Y, Xie Y, Fang W, Liu Z.
    Theranostics; 2019 Oct; 9(25):7583-7598. PubMed ID: 31695788
    [Abstract] [Full Text] [Related]

  • 4. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
    Liu X, Shan W, Li T, Gao X, Kong F, You H, Kong D, Qiao S, Tang R.
    BMC Cancer; 2021 Nov 14; 21(1):1224. PubMed ID: 34775955
    [Abstract] [Full Text] [Related]

  • 5. GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway.
    Xi J, Sun Y, Zhang M, Fa Z, Wan Y, Min Z, Xu H, Xu C, Tang J.
    Exp Cell Res; 2019 Aug 01; 381(1):1-9. PubMed ID: 31054856
    [Abstract] [Full Text] [Related]

  • 6. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 7. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 8. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S, Zhang F, Chen Q, Wan C, Xiong J, Xu J.
    J Exp Clin Cancer Res; 2019 Nov 14; 38(1):467. PubMed ID: 31727171
    [Abstract] [Full Text] [Related]

  • 9. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC, Tung SL, Chen YL, Chen PM, Chu PY.
    BMC Cancer; 2018 May 30; 18(1):609. PubMed ID: 29848298
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M, Bamodu OA, Kuo KT, Lee WH, Lin YK, Wu ATH, M H, Tzeng YM, Yeh CT, Tsai JT.
    Am J Chin Med; 2018 May 30; 46(4):891-910. PubMed ID: 29792038
    [Abstract] [Full Text] [Related]

  • 11. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Seto K, Sakabe T, Itaba N, Azumi J, Oka H, Morimoto M, Umekita Y, Shiota G.
    Anticancer Res; 2017 Jul 30; 37(7):3569-3579. PubMed ID: 28668848
    [Abstract] [Full Text] [Related]

  • 12. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A, Kahya U, Linge A, Chen O, Löck S, Lukiyanchuk V, Richter S, Alves TC, Peitzsch M, Telychko V, Skvortsov S, Negro G, Aschenbrenner B, Skvortsova II, Mirtschink P, Lohaus F, Hölscher T, Neubauer H, Rivandi M, Labitzky V, Lange T, Franken A, Behrens B, Stoecklein NH, Toma M, Sommer U, Zschaeck S, Rehm M, Eisenhofer G, Schwager C, Abdollahi A, Groeben C, Kunz-Schughart LA, Baretton GB, Baumann M, Krause M, Peitzsch C, Dubrovska A.
    Theranostics; 2021 Jul 30; 11(16):7844-7868. PubMed ID: 34335968
    [Abstract] [Full Text] [Related]

  • 13. miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma.
    Zhang X, Jiang P, Shuai L, Chen K, Li Z, Zhang Y, Jiang Y, Li X.
    J Exp Clin Cancer Res; 2016 Nov 11; 35(1):176. PubMed ID: 27835990
    [Abstract] [Full Text] [Related]

  • 14. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
    Lin X, Li AM, Li YH, Luo RC, Zou YJ, Liu YY, Liu C, Xie YY, Zuo S, Liu Z, Liu Z, Fang WY.
    Signal Transduct Target Ther; 2020 Feb 14; 5(1):13. PubMed ID: 32296025
    [Abstract] [Full Text] [Related]

  • 15. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H, Li Y, Li X, Zhang W, Li S, Martin RCG.
    BMC Cancer; 2018 Aug 03; 18(1):783. PubMed ID: 30075764
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
    Sun L, Wang Y, Wang L, Yao B, Chen T, Li Q, Liu Z, Liu R, Niu Y, Song T, Liu Q, Tu K.
    J Exp Clin Cancer Res; 2019 Apr 18; 38(1):170. PubMed ID: 30999932
    [Abstract] [Full Text] [Related]

  • 18. Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma.
    Yu D, Shi X, Meng G, Chen J, Yan C, Jiang Y, Wei J, Ding Y.
    Oncotarget; 2015 Apr 10; 6(10):7619-31. PubMed ID: 25844758
    [Abstract] [Full Text] [Related]

  • 19. 6-C-(E-Phenylethenyl)Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling.
    Kang Q, Gong J, Wang M, Wang Q, Chen F, Cheng KW.
    J Agric Food Chem; 2019 Dec 18; 67(50):13939-13947. PubMed ID: 31769973
    [Abstract] [Full Text] [Related]

  • 20. Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma.
    Chang HL, Bamodu OA, Ong JR, Lee WH, Yeh CT, Tsai JT.
    Cells; 2020 Apr 20; 9(4):. PubMed ID: 32326045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.